Text and Data Mining valid from 2019-01-31
Received: 3 December 2018
Accepted: 11 January 2019
First Online: 31 January 2019
Compliance with ethical standards
: Kazuaki Chayama has received honorarium from MSD, Bristol-Myers Squibb, AbbVie, Ajinomoto Pharma, Abbott, Astellas Pharma, Chugai, Dainippon Sumitomo Pharma, Gilead Sciences, Mitsubishi Tanabe. Kazuaki Chayama has received research funding from Janssen, Mitsubishi Tanabe, Dainippon Sumitomo, Toray. Kazuo Awai has research funding from Canon Medical Systems, Hitachi, Rrserch. Kazuaki Chayama has received educational grants from AbbVie, Dainippon Sumitomo, Ajinomoto Pharma, MSD, Eisai, Toray, Otsuka, Mitsubishi Tanabe, Chugai, Daiichi Sankyo, Takeda, Nippon Kayaku, Bristol-Myers Squibb, Roche.
: All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
: Informed consent was obtained from all patients for being included in the study.